Delayed Wound Closure in Fibromodulin-Deficient Mice is Associated with Increased TGF-β3 Signaling

Zhong Zheng,Calvin Nguyen,Xinli Zhang,Hooman Khorasani,Joyce Z. Wang,Janette N. Zara,Franklin Chu,Wei Yin,Shen Pang,Anh Le,Kang Ting,Chia Soo
DOI: https://doi.org/10.1038/jid.2010.381
2011-01-01
Abstract:Fibromodulin (FMOD), a small leucine-rich proteoglycan, mediates scarless fetal skin wound repair through, in part, transforming growth factor-beta (TGF-beta) modulation. Using an adult fmod-null (fmod(-/-)) mouse model, this study further elucidates the interplay between FMOD and TGF-beta expression during cutaneous repair and scar formation. Full-thickness skin wounds on fmod(-/-) and wild-type (WT) mice were closed primarily and analyzed. Histomorphometry revealed delayed dermal cell migration leading to delayed wound closure and significantly increased scar size in fmod(-/-) mice relative to WT, which was partially rescued by exogenous FMOD administration. In addition, fmod(-/-) wounds exhibited early elevation (within 24 hours post-wounding) of type I and type II TGF-beta receptors as well as unexpectedly high fibroblast expression of TGF-beta 3, a molecule with reported antifibrotic and antimigratory effects. Consistent with elevated fibroblastic TGF-beta 3, fmod(-/-) fibroblasts were significantly less motile than WT fibroblasts. fmod(-/-) fibroblasts were also more susceptible to migration inhibition by TGF-beta 3, leading to profound delays in dermal cell migration. Increased scarring in fmod(-/-) mice indicates that TGF-beta 3's antimotility effects predominate over its antifibrotic effects when high TGF-beta 3 levels disrupt early fibroblastic wound ingress. These studies demonstrate that FMOD presence is critical for proper temporospatial coordination of wound healing events and normal TGF-beta bioactivity.
What problem does this paper attempt to address?